Medicine Description mellitofix-met 12.5/1000 mg
mellitofix met 12.5/1000 mg tablets is a medication that combines two active ingredients: empagliflozin and metformin. Empagliflozin belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by preventing the reabsorption of glucose in the kidneys, thereby promoting its excretion in urine. This action reduces blood glucose levels and aids in weight loss. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity in peripheral tissues, decreases hepatic glucose production, and improves glucose uptake and utilization. Together, these mechanisms provide a dual approach to controlling hyperglycemia in individuals with type 2 diabetes.
Indications and Uses of mellitofix met 12.5/1000 mg tablets
- Management of blood sugar levels in adults with type 2 diabetes.
- As an adjunct to diet and exercise to improve glycemic control.
Side Effects of mellitofix met 12.5/1000 mg tablets
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Fatigue
- Risk of urinary tract infections
- Risk of ketoacidosis
Storage and Handling
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Patient Advice and Precautions
Patients should be counseled to maintain a balanced diet and regular exercise while on this medication. Regular monitoring of blood glucose levels is essential. Inform healthcare providers about any unusual symptoms or side effects, particularly signs of dehydration or ketoacidosis. Avoid excessive alcohol consumption, as it may increase the risk of lactic acidosis.